Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The patients will be randomly assigned to standard therapy or standard therapy+ESP nerve block. After surgery pain level and narcotic consumption will be measured, and vital signs and side effects will bo monitored for up to 72 hours. 6 months after surgery a phone interview will be conducted to asses chronic pain
patients will be divided randomly into two groups before the beginning of operation: Group 1: patients will be treated to standard pain control treatment ; Group 2: patients will receive Erector spinea block (30-40 mL Ropivacaine 0.375% plus 2 mg Dexamethasone injection using ultrasound approach) additionally to standard pain control treatment The ESB (erector spinae plane block) will be performed at the beginning of the procedure while the patient under general anesthesia, in assistance of ultrasound for visualization, anesthetic injection 30-40 mL Ropivacaine 0.375% plus 2 mg Dexamethasone administered on each side between thoracic transversus process and longitudinal spinea muscle. in the the postoperative care room, the vital sings and pain level will be continuously monitored.
During the postoperative period stay the pain level of each patient will be assessed by of Visual Analog Score of pain (VAS: 0-10) interviewing the patient every 30 minutes from the patient's admission from operation room and thereafter every 1 - 4 -8 -12 -24 -48 - 72 hours, at discharge, 7- 14-21 days.
For a more accurate assessment of pain, a pre-operative baseline level of pain eill be recorded.
Any postoperative pain will be routinely managed by 5-10 mg of intravenous morphine to achieve a VAS scale of none or mild pain (1-5). investigators will also continue to record events of postoperative nausea and vomiting (PONV) within 24 hours after procedure. The PONV will be assessed by the PONV Impact Scale score, based on numerical responses to questions. A PONV Impact Scale score of ≥5 defines clinically relevant PONV.
Recording of urinary retention, constipation, opioid requirements and itching will also be preformed.
After 3 and 6 months a telephone survey will be preformed - recording pain related to surgery and to asses chronic pain syndrome. During the phone conversation, patients will be asked to answer by the brief pain inventory.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| standard care | No Intervention | standard analgesic treatment | |
| standard care + ESP block | Experimental | intraoperativeESP block + standard analgesic treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| erector spinea plane block | Procedure | in assistance of ultrasound for visualization anesthetic injection point. 30-40 mL Ropivacaine 0.375% plus 2 mg Dexamethasone administered on each side will be administered between thoracic transversus process and longitudinal spine muscle |
| Measure | Description | Time Frame |
|---|---|---|
| VAS score | the patients reported pain level using the VAS score | postoperative - 1 hour |
| VAS score | the patients reported pain level using the VAS score | postoperative - 4 hour |
| VAS score | the patients reported pain level using the VAS score | postoperative - 8 hour |
| VAS score | the patients reported pain level using the VAS score | postoperative - 12 hour |
| VAS score | the patients reported pain level using the VAS score | postoperative - 24 hour |
| VAS score | the patients reported pain level using the VAS score | postoperative - 48 hour |
| VAS score | the patients reported pain level using the VAS score | postoperative - 72 hour |
| VAS score | the patients reported pain level using the VAS score | day 7 postoperative |
| VAS score |
| Measure | Description | Time Frame |
|---|---|---|
| heart rate | postoperative heart rate | postoperative - 1 hour |
| heart rate | postoperative heart rate | postoperative - 4 hour |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| michael dubilet, md | Contact | 972-54-6260728 | mikl.dubilet@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Soroka Hospital | Recruiting | Beersheba | Israel |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| D009293 | Opioid-Related Disorders |
| D059350 | Chronic Pain |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
Patients will be randomized to 2 groups - standard care vs standard care+ESP block
Not provided
Not provided
The block will be preformed under anesthesia. The patients will not know what intervention group they are allocated
the patients reported pain level using the VAS score
| day 14 postoperative |
| VAS score | the patients reported pain level using the VAS score | day 21 postoperative |
| opioid consumption | total morphine administered (in mg) | postoperative - 24 hours |
| opioid consumption | total morphine administered (in mg) | postoperative - 72 hours |
| heart rate | postoperative heart rate | postoperative - 8 hour |
| heart rate | postoperative heart rate | postoperative - 12 hour |
| heart rate | postoperative heart rate | postoperative - 24 hour |
| blood pressure | postoperative blood pressure - systolic and diastolic | postoperative - 1 hour |
| blood pressure | postoperative blood pressure - systolic and diastolic | postoperative - 4 hour |
| blood pressure | postoperative blood pressure - systolic and diastolic | postoperative - 8 hour |
| blood pressure | postoperative blood pressure - systolic and diastolic | postoperative - 12 hour |
| blood pressure | postoperative blood pressure - systolic and diastolic | postoperative - 24 hour |
| PONV | post operative nausea and vomiting (PONV) assessed by the PONV impact scale score | postoperative - 1 hour |
| PONV | post operative nausea and vomiting (PONV) assessed by the PONV impact scale score | postoperative - 4 hour |
| PONV | post operative nausea and vomiting (PONV) assessed by the PONV impact scale score | postoperative - 8 hour |
| PONV | post operative nausea and vomiting (PONV) assessed by the PONV impact scale score | postoperative - 12 hour |
| PONV | post operative nausea and vomiting (PONV) assessed by the PONV impact scale score | postoperative - 24 hour |
| chronic pain - VAS | patient's self reported current pain score (VAS) over a telephone interview | postoperative - 3 months |
| chronic pain - VAS | patient's self reported current pain score (VAS) over a telephone interview | postoperative - 6 months |
| chronic pain - opioid use | patient's self reported current use of opioids over a telephone interview | postoperative - 3 months |
| chronic pain - opioid use | patient's self reported current use of opioids over a telephone interview | postoperative - 6 months |
| chronic pain - sleep | patient's self reported difficulty sleeping due to pain over a telephone interview | postoperative - 3 months |
| chronic pain - sleep | patient's self reported difficulty sleeping due to pain over a telephone interview | postoperative - 6 months |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D000079524 | Narcotic-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |